• BODIPY 581/591 C11: Ratiometric Fluorescent Probe for Lipid

  2026-07-08

  BODIPY 581/591 C11 is a ratiometric fluorescent probe enabling quantitative lipid peroxidation detection and oxidative stress measurement in biological systems. Its red-to-green spectral shift upon oxidation provides high sensitivity for antioxidant capacity evaluation. The probe is widely adopted in ferroptosis and membrane biology research.

• PTX3 Counters Steroid-Induced ONFH via TLR4/NF-κB-FGF21 Axis

  2026-07-08

  Li et al. (2025) demonstrate that pentraxin 3 (PTX3) mitigates glucocorticoid-induced osteonecrosis of the femoral head (ONFH) by modulating the TLR4/NF-κB/FGF21 signaling pathway. This mechanistic insight reveals a new axis for targeting bone loss and provides a foundation for future therapeutic strategies in steroid-associated bone disease.

• Olsalazine Sodium in Cancer Research: Protocols and Innovati

  2026-07-07

  Olsalazine Sodium stands out as a powerful mesalamine dimer for inflammation and cancer models, offering robust inhibition of LTB4-induced chemotaxis and proven tumor-suppressive effects. This article delivers practical workflows, optimization strategies, and actionable troubleshooting tips supported by recent transporter research and APExBIO’s validated supply chain.

• gamma-Glu-Cys (γ-Glu-Cys): Technical Guide for Lab Workflows

  2026-07-07

  gamma-Glu-Cys (γ-Glu-Cys) is a high-purity intermediate tailored for glutathione metabolism research, thiol-reactive peptide synthesis, and plant stress adaptation workflows. It provides well-characterized substrate properties and supports reproducible enzyme assays. This reagent is not intended for clinical, diagnostic, or in vivo applications and should be reserved for controlled laboratory studies.

• Practical Guide to Thiazovivin (A5506) for Stem Cell Researc

  2026-07-06

  Thiazovivin is a ROCK inhibitor that enhances fibroblast reprogramming efficiency and supports human embryonic stem cell (hESC) survival after dissociation. It is best used in in vitro stem cell workflows requiring improved cellular viability and reprogramming, but is not suitable for diagnostic or clinical applications. Long-term solution storage is also not recommended.

• Nystatin (Fungicidin): Applied Antifungal Workflows & Troubl

  2026-07-06

  Nystatin (Fungicidin) from APExBIO empowers high-precision antifungal research, addressing current challenges in Candida and Aspergillus studies. This guide details experimental workflows, highlights a recent synergy breakthrough, and delivers actionable troubleshooting for robust, reproducible results.

• Cy5 Goat Anti-Rabbit IgG (H+L) Antibody: Amplifying Fluoresc

  2026-07-05

  The Cy5 Goat Anti-Rabbit IgG (H+L) Antibody unlocks ultra-sensitive, multiplexed detection for immunofluorescence and immunohistochemistry. Optimized for robust fluorescence and minimal cross-reactivity, it empowers advanced workflows in antiviral innate immunity research and beyond.

• Fasudil (HA-1077) HCl: Precision ROCK Inhibition Workflows

  2026-07-04

  Fasudil (HA-1077) HCl, a selective ROCK inhibitor from APExBIO, empowers reproducible Rho/ROCK pathway inhibition across cancer and disease models. Explore data-driven protocols, troubleshooting strategies, and cross-pathway insights to elevate experimental design and maximize scientific impact.

• 2-Hydroxypropyl-β-cyclodextrin: Technical Use and Protocol G

  2026-07-03

  2-Hydroxypropyl-β-cyclodextrin addresses the solubility challenges associated with poorly water-soluble, hydrophobic compounds—especially those containing aromatic or phenyl groups—by forming inclusion complexes that increase aqueous solubility. It is validated for use as a drug formulation excipient or solubility enhancer in pharmaceutical and biochemical research workflows; its application outside these domains is not supported by current product or internal documentation.

• EPZ5676: Redefining DOT1L Inhibition for Precision Epigeneti

  2026-07-03

  Explore how EPZ5676, a potent DOT1L inhibitor, advances precision epigenetic research and MLL-rearranged leukemia treatment. This article provides unique protocol guidance and bridges molecular mechanism with assay optimization.

• CAV-1, Mitochondrial Cholesterol, and Mitophagy in Liver Can

  2026-07-02

  This study uncovers how celastrol disrupts the CAV-1/SCP2 axis to induce mitochondrial cholesterol accumulation and mitophagy, suppressing liver cancer growth. The findings highlight a novel metabolic vulnerability and suggest that targeting organelle-specific cholesterol dynamics could offer new therapeutic strategies.

• Curcumin Suppresses PBDE-47-Induced NET Formation via ROS/Nr

  2026-07-02

  This study reveals that curcumin inhibits the formation of neutrophil extracellular traps (NETs) induced by the pollutant PBDE-47 through suppression of reactive oxygen species (ROS) via the Nrf2 pathway. The findings provide mechanistic insight into PBDE-47 cytotoxicity and suggest curcumin as a candidate for mitigating immune injury caused by environmental contaminants.

• Apigenin: Network Pharmacology and HDAC Inhibition in Oncolo

  2026-07-01

  Explore Apigenin, a plant-derived flavonoid, as a dual-action molecule targeting histone deacetylase (HDAC) inhibition in malignant mesothelioma and network-modulated neuroprotection. This article uniquely connects dose-response protocol insights and network medicine discoveries to practical research workflows.

• MG-262 (Z-Leu-Leu-Leu-B(OH)2): Precision in Proteasome Inhib

  2026-07-01

  MG-262 (Z-Leu-Leu-Leu-B(OH)2) stands out as a potent, reversible, and cell-permeable proteasome inhibitor, empowering researchers to dissect ubiquitin-proteasome dynamics in muscle aging, apoptosis, and cell cycle studies. This guide delivers actionable workflows, troubleshooting insights, and context from the latest autophagy research to maximize MG-262's experimental impact.

• Ultrasonically Powered Implantable TTFs for Localized Cancer

  2026-06-30

  This study introduces a wireless, battery-free implantable Tumor Treating Field (i-TTF) system powered by focused ultrasound and shape-engineered BaTiO3 nanoparticle-based receivers. The approach enhances energy transfer efficiency, field localization, and safety for glioblastoma treatment, with demonstrated anti-proliferative effects both in vitro and in vivo.

16282 records 1/1086 page Next 12345 下5页 Last page